Neuropathic & Intraoral Pain Flashcards

1
Q

Neuropathic
pain

A

Pain caused by a lesion or disease of the
somatosensory nervous system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Episodic
(Paroxysmal)
(4)

A

a. Trigeminal neuralgia
b. Glossopharyngeal neuralgia
c. Occipital neuralgia
d. Nervus intermedius neuralgia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

skipped
Continuous
(5)

A

a. Persistent idiopathic facial pain
b. Painful post-traumatic trigeminal
neuropathy
c. Trigeminal post-herpetic neuralgia
d. Burning mouth syndrome
e. Occlusal dysesthesia (phantom
bite/occlusion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Nociceptive
(somatic) pain

A

Pain that arises from actual or
threatened damage to non-neural
tissue and is due to the activation
of nociceptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Superficial
somatic pain
(2)

A

a. Cutaneous pain
b. Muco-gingival
pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Deep somatic
pain
(2)

A

a. Muscoluskeletal
pain
b. Visceral pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Neuropathic
Pain
 Definition:

A

 Pain initiated or caused by a primary
lesion or dysfunction in the nervous
system (1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dysesthesia-

A

an unpleasant
abnormal sensation, whether
spontaneous or evoked (1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Neuropathic Pain
Dysfunction may be caused by:
(5)

A
  1. virus (i.e. herpes zoster, shingles)
  2. demyelinating disease (i.e. multiple sclerosis)
  3. trauma, injury, surgery
  4. dental extractions, root canal therapy, dental
    implant placement, restorative procedures
  5. Idiopathic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Neuropathic Pain
Often misdiagnosed & mistreated by

A

doing multiple unnecessary dental
procedures (i.e. multiple root canals,
extractions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

 Inferior Alveolar Nerve
(IAN) Injury incidence
varies from –%
 IAN is the most
commonly injured
nerve —%
 Lingual nerve injury
incidences is —%

A

0-40
64.4
28.8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Etiology
- Intra-operative
(5)
- Post-operative
(2)

A
  • Mechanical
  • Injection needle
  • Implant Drill
  • Thermal
  • Chemical
  • Thermal Stimuli
  • Peri-implant infection and hematoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

IAN injury due to traumatic local anesthesia injection
- –% of the long beveled needles were barbed at
their tips after the procedure
- –% of the patients got an “electric shock
type” sensation on IAN block
- –% of the –% suffer from prolonged
neuropathy

A

78
1.3 – 8.6
57
1.3-8.6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

IAN injury due traumatic local anesthesia injection
- Local anesthetics represent the safest and most effective
drugs in all medicine for the prevention and
management of pain
- — being the least irritant followed by (3)

A

Lidocaine

articaine,
mepivicaine and bupivicaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Neuropathic pain
* can vary widely in clinical
presentation in regard to
* can be caused by either —
and/or by —
* somewhat less responsive to
— and more likely to respond
to other drugs, such as
— (among others)
* can be —evoked or
—independent
(spontaneous).

A

pain
quality and location
central
nervous system dysfunction
peripheral nerve
lesions.
opioids
anticonvulsants
stimulus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  • CENTRAL CAUSES OF FACIAL PAIN
    (6)
A

– Anesthesia dolorosa (pain in an area that is anesthetic)
– Central post-stroke pain
– Facial pain attributed to multiple sclerosis
– Persistent idiopathic facial pain (previously known as atypical face pain)
– Burning mouth syndrome
– Multiple sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

skipped
NEURALGIAS – follows distribution of a nerve(s)
(9)

A

– Trigeminal neuralgia
– Post-herpetic neuralgia
– Traumatic neuralgia
– Glossopharyngeal neuralgia
– Occipital neuralgia
– Superior laryngeal neuralgia (from branch of CN X)

Geniculate neuralgia (Ramsay Hunt/Nervus
intermediate neuralgia)- sensory of CN VII with lancinating pain
– in the auditory canal/middle ear
Auriculotemporal neuralgia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
  • OTHER CAUSES
    (5)
A

– Cancer pain
– Dental pain
– Post-traumatic and post-surgical pain
– Primary headache
– Temporomandibular joint syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Neuralgia
 Definition:

A

 “Paroxysmal or constant pain typically with sharp, stabbing,
itching, or burning character in the distribution of a nerve “

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Neuralgia
* a form of neuropathic pain that is characterized by the
following features:
1. …
2. Typically, there is no objective — in the
distribution of the affected nerve
3. Attacks can be provoked by …
4. A — period follows attacks; the duration of the
— period shortens as the disease progresses

A

Paroxysmal, brief (seconds to a few minutes), shock-like or
lightning-like pain that follows a peripheral or cranial
nerve distribution and can spread to adjacent areas in the
course of the attack
neurologic deficit
non-painful stimulation
(allodynia) of trigger zones (i.e. flossing elicits gingival
pain)
refractory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Pre-trigeminal
neuralgia
 …
 Pain duration varies widely
from —
 Pain may go into —
 This brief, milder pain is
sometimes suspected to
have a dental origin and
unnecessary dental
procedures have been
performed in many cases

A

Dull, continuous, aching or
burning pain in the oral
cavity or teeth or jaw
evolving eventually into
trigeminal neuralgia (TN)
hours to months
remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Trigeminal neuralgia
(TN)

A

The International Association for
the Study of Pain (IASP) defines TN
as sudden, usually unilateral,
severe, brief, stabbing or
lancinating, recurrent episodes of
pain in the distribution of one or
more branches of the fifth cranial
(trigeminal) nerve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

EPIDEMIOLOGY
* The annual incidence of TN is — per 100,000
people
* — new cases occur in the US each year.
* TN is one of the most frequently seen neuralgias in the —.
* incidence increases with —
* Onset after age —, although may occur in the second and third decades or, rarely, in children.
* male to female ratio is about —

A

4 to 13
15,000
elderly
age
50
1:1.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Pathophysiology
* Most cases of trigeminal neuralgia (TN) are caused
by

A

compression of the trigeminal nerve root, usually
within a few millimeters of entry into the pons
* Compression by an aberrant loop of an artery or vein is
thought to account for 80 to 90 percent of cases.
* Other causes of nerve compression include
* vestibular schwannoma (acoustic neuroma)
* Meningioma
* epidermoid or other cyst,
* saccular aneurysm or AV malformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Focal Demyelination

A

Causes ectopic firing of nerve due to demyelination disrupting normal
nerve transmission.

26
Q

– fibers-most
susceptible to
demyelination due
to compression,or
MS-areas of
segmental
demyelination are
the location of
ectopic impulse
generation
Cruccu et al., 2020

A

A-β

27
Q

CLINICAL FEATURES
* The pain of TN tends to occur in — and is
maximal at or near onset.
* The pain
(5)
* (2) are involved more frequently than —
* — in most cases
* Facial muscle spasms can be seen with severe pain
especially the — muscle

A

paroxysms

  • “electric shock-like” or “stabbing“
  • typically does not awaken patients at night.
  • lasts from several seconds to minutes, but may occur
    repetitively
  • A refractory period of several minutes during which a paroxysm
    cannot be provoked is common due to nerve repolarization
  • may also be a co-existing continuous, deep, dull pain.

V2 and/or V3, V1
unilateral
masseter

28
Q

Clinical Features
 TN can be precipitated by …
 — may be present
 Triggers can be (11)
 Episodes may last —, followed by pain-free intervals or remission of pain for years.
 Recurrence is common

A

dental procedures (i.e. root
canal therapy, dental extraction)
Trigger zones
light touching, chewing, talking,
brushing teeth, cold air, smiling, shaving, washing face
and/or grimacing, brushing or flossing teeth.
weeks or months

29
Q

13.1.1 Classical trigeminal
neuralgia
A. At least – attacks of unilateral facial pain fulfilling
criteria B and C
B. In – divisions of trigeminal nerve, with no radiation
beyond trigeminal distribution
C. Pain has ≥3 of the following 4 characteristics:

D. No clinically evident neurological deficit
E. Not better accounted for by another ICHD-3 diagnosis

A

3
≥1
1. recurring in paroxysmal attacks lasting from a fraction
of a second to 2 minutes
2. severe intensity
3. electric shock-like, shooting, stabbing or sharp in
quality
4. precipitated by innocuous stimuli to affected side of
face

30
Q

Differential diagnosis
(5)

A
  1. Short-lasting unilateral neuralgiform headache with
    conjunctival injection and tearing (SUNCT)
  2. Cluster-tic syndrome
  3. Giant Cell Arteritis
  4. Multiple sclerosis
  5. Other neuralgias
31
Q

Imaging studies to
rule out brain
pathology
* Magnetic resonance imaging (MRI) or
magnetic resonance angiography
(MRA) of the brain
* MRI should be obtained in the
following groups to rule out a mass
lesion or multiple sclerosis:
(4)

A
  • Patients with sensory loss
  • Young patients (under the age of
    40)
  • Patients with bilateral symptoms
  • Patients who do not respond to
    conservative therapy
32
Q

SURGICAL THERAPY FOR TN
(6)

A

 Microvascular decompression
 Radiofrequency rhizotomy
 Glycerol rhizolysis
 Balloon compression
 Gamma knife radiosurgery – NON-INVASIVE
 Peripheral neurectomy (not recommended)

33
Q

Gamma Knife Radiation:
Neuroablative Procedure
(2)

A

 Destroys portions of the
nervous system to block
transmission of nociceptive
information.
 Nociception: a complex series
of electrochemical events that
occurs between a site of active
tissue damage and the
perception of pain

34
Q

Pathophysiology - Microvascular
Compression theory
(4)

A

 Compression of the trigeminal nerve
root at or near the dorsal root entry
zone by a blood vessel (usually the
superior cerebellar artery)
 Segmental demyelination of A-beta
and A-delta fibers at the site of
vascular compression
 Generation of ectopic impulses and
spreading of these impulses to
adjacent neurons through ephaptic
transmission (cross-talk)
 Microvascular Decompression
Surgery can improve Trigeminal
Neuralgia pain

35
Q

Herpes Zoster (HZ) Virus
HZ (shingles) features:
(4)

A

 acute inflammation caused by varicella zoster virus (chickenpox)
 Multiple, painful vesicular skin or mucosal eruptions
 Occurs in cutaneous areas supplied by the cranial or spinal nerve
ganglia inflamed by the virus causing necrosis & hemorrhage
 Pain subsides within weeks typically but can last months to years
then classified as Post-herpetic neuralgia

36
Q

Herpes Zoster (HZ)
 Commonly affects:
 1. — if spinal nerves involved
 2. trigeminal nerve(V1) if cranial nerves involved and may cause

 3. facial nerve (VII) causing …
 4. C2 & C3 causing pain over …

 Treatment:

A

torso
blindness and palsies affecting CN III, IV, VI.
facial weakness, hearing loss, tinnitus.
posterior head.

anti-virals and steroids as soon as possible. Pain
medications to manage pain.

37
Q

Vaccine for Shingles Prevention
(2)

A
  • (CDC) recommends that appropriate adults 50 or older get
    vaccinated to help prevent Shingles.
  • Shingrix (recombinant zoster vaccine) the preferred
    vaccine over ZOSTAVAX (“ZOS-tah-vax”)to help reduce your
    risk of getting Shingles in the future.
38
Q

POST-HERPETIC NEURALGIA
(PHN)
 a common form of …
 Risk of developing PHN increases with age & affects –%
of patients > 60 years old
 A pain developed during the — phase of HZ and
recurring or persisting for more than – months after the
onset of the HZ.
 Risk factors:
 a — component may contribute to the varied
susceptibility of some patients to developing PHN after
an attack of HZ.

A

chronic neuropathic pain
60
acute,3
age, female, prodrome, etc.
genetic

39
Q

Post-Herpetic Neuralgia
 Clinical Characteristics:
(3)

A

 a constant, deep, aching/burning pain; a brief, intense shooting
pain with hyperalgesia (an increased response to a
 stimulus that is normally painful) or allodynia (pain due to a
stimulus that does not normally provoke pain) ( with light touch
producing pain (80-90%).
 May be superimposed brief stabbing exacerbations of pain

40
Q

Post-Herpetic Neuralgia
 Pathophysiology:
(3)

A

 sensory deficits in the affected dermatomes as well as pigmentary
changes and scarring.
 Major degenerative changes occur in afferent pathways with loss
of axons and myelin in peripheral sensory nerves.
 Both peripheral and central mechanisms are involved in PHN.

41
Q

Management of PHN PAIN
Systemic
(6)

A

 a SNRI/TCAs, such as
amitriptyline/nortriptyline
 Gabapentin/pregabalin may
be as effective as TCAs
with fewer
contraindications
 Lyrica
 Opioids
 Steroids
 NSAIDs

42
Q

Management of PHN PAIN
Topicals
(8)

A

 5% lidocaine patches
 NSAID gel or cream – Diclofenac
 Sodium topical gel 1%
 Shingles gel:
 Amitriptyline (2%)
 Ketoprofen (10%)
 Tetracaine (4%)
 Deoxy d-glucose

43
Q

3.18.4 Persistent idiopathic
facial pain (PIFP)
(6)

A

A. Facial and/or oral pain fulfilling criteria B and C
B. Recurring daily for >2 h per day for >3 mo
C. Pain has both of the following characteristics:
1. poorly localized, and not following distribution of a
peripheral nerve
2. dull, aching or nagging quality
D. Clinical neurological examination is normal
E. Dental cause excluded by appropriate investigations
F. Not better accounted for by another ICHD-3 diagnosis

44
Q

Persistent Idiopathic Facial Pain
(trigeminal deafferentation pain)
(4)

A
  • PIFP is best defined as persistent pain in apparently
    normal teeth or adjacent oral tissues
  • (phantom tooth pain, idiopathic toothache, idiopathic
    odontalgia, facial migraine, atypical facial neuralgia,
    and atypical facial pain have been used in the past)
  • Affects women in the fourth or fifth decade (peri-
    menopausal or menopausal)
  • Previously called Atypical Toothache
45
Q

Persistent Idiopathic Facial Pain
(trigeminal deafferentation pain)
* Precipitating factors:
(3)
* AO is more likely to develop in a tooth that was painful
immediately prior to any dental intervention.

A
  1. traumatic injury
  2. various routine dental procedures such as endodontic
    therapy, apicoectomy, tooth extraction, periodontal
    surgery, or implants.
  3. can even follow seemingly innocuous dental procedures
    such as crown preparation, drilling of dentin and
    periodontal scaling.
46
Q

skipped
Differential Diagnosis of
PIFP
(7)

A

 Odontogenic toothache
 Myofascial trigger point pain
 Pre-Trigeminal neuralgia
 Neurovascular toothache (facial or midface migraine,
cluster headache)
 Maxillary sinusitis
 Neuritic toothache
 Temporomandibular disorder (TMD)

47
Q

Diagnostic Workup
 Obtain a thorough —
 eliminate any — cause
 R/O a
 PIFP frequently arises spontaneously and is not related
to functional demands. However, the tooth may be
sensitive to — and a patient may complain of pain
on eating

A

history
odontogenic
myofascial trigger point, trigeminal neuralgia,
neurovascular toothache due to facial or midface
migraine or cluster headache(episodic and throbbing or
pulsating), tooth pain from a maxillary sinusitis /
neuritic toothache/
pressure

48
Q

skipped
Persistent Idiopathic Facial Pain Treatment
(Anti-epileptics or Membrane Stabilizers)
 Medications: Dosage(mg/day)
(8)

A

 Tegretol (carbamazepine) 200-1200
 Baclofen (Lioresal) 10-80
 Neurontin (gabapentin) 300-3000
 Depakote (divalproex sodium) 125-2000
 Klonopin (clonazepam) 0.5-8
 Phenytoin (Dilantin) 100-400
 Trileptal (oxcarbazepine) 600-1200
 Topomax (topiramate) 400-1200

49
Q

skipped
Central Acting
Medications
(Antidepressants)
 Medications: Dosage(mg/day)
(6)

A

 Amitriptyline (Elavil) 10-150
 Desipramine (Norpramin) 10-150
 Doxepin (Sinequan) 10-150
 Imipramine (Tofranil) 10-150
 Nortriptyline (Pamelor) 10-150
 Trazodone (Desyrel) 50-300

50
Q

skipped
Topical Medications
(5)

A

 Viscous Lidocaine
 Topical Ketamine
 Zostrix (OTC) – contains capsaicin- depletes substance P
 NOTE: These medications may be combined & used in a
stent as a medication delivery system.
 Stent covers sensitive gingival tissue.

51
Q

Burning Mouth Syndrome
* characterized by
* Other associated common conditions :

A

an intraoral burning sensation for which no medical or
dental cause can be found

– psychiatric disorders such as depression
– xerostomia (from drugs, connective tissue disease, or age)
– nutritional deficiencies (vitamin B12, iron, folate, zinc, vitamin B6) so blood tests
needed first to rule out vitamin deficiency
– allergic contact stomatitis- (i.e. denture acrylic or nickel clasps)
– geographic tongue
– candidiasis
– diabetes
– denture-related pain
– thyroid abnormalities
– menopause

52
Q

Burning Mouth Syndrome
Epidemiology
& Treatment
 predominantly affects
 — % improve spontaneously
 The frequency of burning mouth
syndrome are unknown
 Topical — troches (4mg)
dissolve in mouth up to 3x/day
 — (sedating)

A

women
especially post-menopausal due to
decreased estrogen
30 - 50
amitriptyline
Klonopin

53
Q

IHS Diagnostic Criteria Beta III
13.10 Burning mouth syndrome (BMS)
A. Oral pain fulfilling criteria B and C
B. Recurring daily for – h per day for – mo
C. Pain has both of the following characteristics:
… …
D. Oral mucosa is of normal appearance and clinical
examination including sensory testing is normal
E. Not better accounted for by another ICHD-3 diagnosis

A

> 2
3

  1. burning quality
  2. felt superficially in the oral mucosa
54
Q

Site of Oral Burning
 Oral pain represents the cardinal
symptom of BMS
 Type of pain is a prolonged “—”
sensation
 Distribution of the burning sensation is
nearly always — but it does not
follow anatomical landmarks
 Most common site is …

A

burning
bilateral
anterior two-thirds
and tip of the tongue.

55
Q

Site of Oral
Burning
(2)
 Many patients complain of burning
in

A

 Anterior hard palate, mucosal
aspect of lower lip, and
mandibular alveolar regions are
also affected.
 Buccal mucosa and floor of mouth
rarely involved.

more than one intraoral area at
the same time

56
Q

Oral Burning
 Onset :
 — with no known precipitating factors
 Sudden and linked to a …

 The timing of the symptoms is variable.
 Some patients complain of — discomfort
throughout the day
 Others find that it gradually increases during the day and
reaches maximum intensity by —
 Pain usually — nightly during sleep

A

Gradual
preceding dental procedure (tooth
cleaning, filling or a new denture), upper respiratory
infection or a course of antibiotics.
continuous
evening
remits

57
Q

Burning mouth syndrome
Management
Medication
(5)
Surgical therapy
(1)

A

 Clonazepam (“topical”)
 Alpha-lipoic acid
 Tricyclic anti-
depressants:
(Amitriptyline) oral or
as a troche 4mg tid
 Gabapentin
 Pregablin

  • No surgical treatment is
    recommended
58
Q

Glossopharyngeal
Neuralgia
 Severe paroxysmal, lancinating pain that
radiates to the …
 Rare, — condition
 Affects
 Triggered by movement in the …
 Due to a lesion in the petrosal and
jugular ganglion of CN —
 Branches of carotid artery can trigger a …

A

throat, ear, teeth and
tongue
unilateral
males > age 50 years
tonsillar region by swallowing or coughing
IX
vasovagal response (i.e. BP, cardiac
output, altered respiration)

59
Q

Geniculate
Neuralgia
 Known as nervus intermedius
neuralgia, Ramsay Hunt’s
syndrome
 Painful disturbance of the
sensory portion of the —
 Causes lancinating pain in the…
 Treatment:

A

Facial
nerve - CN VII
middle ear and the auditory
canal

Methyl
prednisone (10mg) start with
80mg dose, then taper by 10
mg every 3 days until 20 mg
dose. Maintain pt on 20mg for
14 days then taper off.

60
Q

Eagle’s syndrome
 What?
 Symptoms: (6)
 Pain may occur with swallowing, talking, chewing,
turning the head to the contralateral side, yawning
 Usually unilateral, constant, deep, throbbing or aching
 Exam:
 Radiograph:
 Refer to Ear, Nose & Throat (ENT) specialist

A

Elongation or ossification of the stylohyoid ligament

sore throat, dysphagia, otalgia, glossodynia,
headache or vague pain in the neck

includes palpation of the stylohyoid area to
attempt to reproduce pain & turning head to side

reveals elongated stylohyoid process

61
Q
A